Page last updated: 2024-12-08

beta-methylcrotonylglycine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

beta-methylcrotonylglycine: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

3-methylcrotonyl glycine : An N-acylglycine in which the acyl group is specified as 3-methylbut-2-enoyl. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID169485
CHEBI ID68499
SCHEMBL ID232926
SCHEMBL ID21594819
MeSH IDM0042656

Synonyms (32)

Synonym
beta-methylcrotonylglycine
n-(3,3-dimethylacrylyl)glycine
n-(3-methyl-1-oxo-2-butenyl)glycine
33008-07-0
3-methylcrotonyl glycine
2-(3-methylbut-2-enoylamino)acetic acid
3-methylcrotonylglycine
glycine, n-(3-methyl-1-oxo-2-butenyl)-
unii-lhg2sn5poh
lhg2sn5poh ,
AKOS009281165
FT-0671623
CHEBI:68499
n-(3-methylbut-2-enoyl)glycine
SCHEMBL232926
C20828
2-(3-methylbut-2-enamido)acetic acid
DTXSID50186641
J-018974
3-methylcrotonyl-glycine
n-(3-methyl-1-oxo-2-butenyl)-glycine
3-methylcrotonylglycin
HY-113232
CS-0059371
SCHEMBL21594819
Q27136979
DS-19658
.beta.-methylcrotonylglycine
glycine, n-(3-methyl-1-oxo-2-buten-1-yl)-
2-(3-methylbut-2-enamido)aceticacid
mfcd10692260
PD076226

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"Biotin deficiency associated with total parenteral nutrition is an emerging clinical problem; criteria for diagnosis and dosage for treatment are unclear."( Biotin deficiency complicating parenteral alimentation: diagnosis, metabolic repercussions, and treatment.
Baker, H; Baswell, DL; Holman, RT; Mock, DM; Sweetman, L, 1985
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
N-acylglycineAn N-acyl-amino acid in which amino acid specified is glycine.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
Leucine, isoleucine and valine metabolism2470

Research

Studies (27)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (33.33)18.7374
1990's5 (18.52)18.2507
2000's9 (33.33)29.6817
2010's4 (14.81)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.09

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.09 (24.57)
Research Supply Index3.33 (2.92)
Research Growth Index4.42 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.09)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (7.41%)6.00%
Case Studies16 (59.26%)4.05%
Observational0 (0.00%)0.25%
Other9 (33.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]